US Patent Issued to Hangzhou Tianlong Pharmaceutical on Nov. 25 for "Herpes zoster mRNA vaccine, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,669, issued on Nov. 25, was assigned to Hangzhou Tianlong Pharmaceutical Co. Ltd. (Hangzhou, China).

"Herpes zoster mRNA vaccine, preparation method therefor, and use thereof" was invented by Gengshen Song (Zhejiang, China), Kai Dong (Zhejiang, China), Zhongbin Chen (Zhejiang, China), Yanfen Li (Zhejiang, China), Yuting Zhou (Zhejiang, China), Jing Li (Zhejiang, China), Xin Chai (Zhejiang, China), Zhongcai Gao (Zhejiang, China), Jinyu Zhang (Zhejiang, China) and Huanyu Wang (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure belongs to the technical field of mRNA vaccines, and specifically relates to a herpes zoste...